ANALYSIS-U.S. move to negotiate drug prices a rare defeat for Big Pharma
13/8 01:46
Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but still suffered a major defeat after failing to stop a bill that allows the government to negotiate prices on select drugs....